SUBSCRIBE
SUBSCRIBE

Sanofi US

NEWS
Life Science's Fastest Growing Job Right Now
Drug Development
Esperion’s Cholesterol Drug Positive in PhIII Trial
Esperion announced that its bempedoic acid for lowering LDL-C cholesterol had positive results in a Phase III clinical trial.
March 7, 2018
 · 
3 min read
 · 
Mark Terry
Can 2018 Possibly Rival 2017’s Biotechs Record Ven
Biotech Bay
VCs Are Pouring Billions into Biotech in 2018
While the focus has been on M&A activity, Venture Capital firms have been investing billions in Biotech companies in 2018.
March 6, 2018
 · 
3 min read
 · 
Mark Terry
Drug Development
Sanofi and Regeneron Seek FDA Approval of Dupixent as Add-On Asthma Therapy
Asthma patients may soon have a new treatment option.
March 2, 2018
 · 
2 min read
 · 
Alex Keown
Biotech Bay
Desperate But Not Crazy
April 1, 2008
 · 
2 min read
BioMidwest
Cheaper Blood Thinner Just As Effective, Study Says
August 23, 2006
 · 
1 min read
Policy
Sanofi-Aventis (France) Defends Ambien Sleeping Pill
March 23, 2006
 · 
1 min read
BioMidwest
Sanofi-Aventis (France) Ambien May Prompt Sleep-Eating
March 15, 2006
 · 
1 min read
BioCapital
World Health Organization Calls For Halt On Malaria Treatment
January 19, 2006
 · 
1 min read
The Day In Review: Biotech Marks 5-Year Anniversary Of Nasdaq Bubble Quietly
October 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
September 29, 2025
 · 
5 min read
Press Releases
Libertas Bio, a Formation Bio subsidiary, License of Gusacitinib, a Dual JAK/SYK Inhibitor, to Sanofi
June 23, 2025
 · 
2 min read
Press Releases
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
May 30, 2025
 · 
16 min read
Press Releases
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
May 23, 2025
 · 
5 min read
Press Releases
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
April 2, 2025
 · 
7 min read
Press Releases
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
March 17, 2025
 · 
7 min read
Press Releases
Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program
December 6, 2024
 · 
2 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
 · 
5 min read
Press Releases
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
July 26, 2024
 · 
4 min read
Press Releases
Sanofi ships U.S. influenza vaccines for the 2024/25 season
July 11, 2024
 · 
7 min read
Load More